TE_12375
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 216.12 |
| Counts of samples | TCGA_tumor:766; TCGA_normal:1; GTEx:2 |
| TSS | chr5(+):25384170 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_12375.1 | - | Intergenic | Non-coding | Non-coding | chr5(+):25384171,25384298,25384445,25384558,25472850,25472870 |
| teRNA_12375.2 | - | Intergenic | Non-coding | Non-coding | chr5(+):25384171,25384298,25384445,25384558,25421335,25421355 |
| teRNA_12375.3 | - | Intergenic | Non-coding | Non-coding | chr5(+):25384171,25384298,25384445,25384558,25408836,25408856 |
| teRNA_12375.4 | - | Intergenic | Non-coding | Non-coding | chr5(+):25384171,25384298,25384445,25384558,25432649,25432669 |
| teRNA_12375.5 | - | Intergenic | Non-coding | Non-coding | chr5(+):25384171,25384298,25384445,25384558,25415402,25415422 |
| teRNA_12375.6 | - | Intergenic | Non-coding | Non-coding | chr5(+):25384171,25384298,25384445,25384558,25393496,25393516 |
| teRNA_12375.7 | - | Intergenic | Non-coding | Non-coding | chr5(+):25384171,25384298,25384445,25384558,25539485,25539505 |
| teRNA_12375.8 | - | Intergenic | Non-coding | Non-coding | chr5(+):25384171,25384298,25384445,25384558,25572508,25572560,25581459,25581479 |
| teRNA_12375.9 | - | Intergenic | Non-coding | Non-coding | chr5(+):25384171,25384298,25384445,25384558,25404715,25404735 |
| teRNA_12375.10 | - | Intergenic | Non-coding | Non-coding | chr5(+):25384171,25384298,25384445,25384558,25395095,25395115 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
